Real-world efficacy of single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
Khwaja J, Bomsztyk J, Atta M, Bygrave C, Forbes A, Durairaj S, Fernandes S, Taylor J, Paterson P, Brearton G, Crawley C, Sheehy O, Brown R, Soutar R, Garg M, Rydzewski A, Jamroziak K, Mahmood S, Wechalekar AD.
Khwaja J, et al. Among authors: soutar r.
Br J Haematol. 2024 May;204(5):1811-1815. doi: 10.1111/bjh.19286. Epub 2024 Jan 3.
Br J Haematol. 2024.
PMID: 38171355